| Date | TitleTitle | ||||
|---|---|---|---|---|---|
| 01/10/15 | 15:00:09 | 1 Oct 2015 | Director/PDMR Shareholding | RNS | |
| 28/09/15 | 15:30:13 | 28 Sept 2015 | Director/PDMR Shareholding | RNS | |
| 28/09/15 | 15:30:13 | 28 Sept 2015 | Director/PDMR Shareholding | RNS | |
| 04/09/15 | 08:00:09 | 4 Sept 2015 | US FDA APPROVES EXPANDED INDICATION FOR BRILINTA | RNS | |
| 01/09/15 | 12:30:04 | 1 Sept 2015 | Total Voting Rights | RNS | |
| 01/09/15 | 08:04:02 | 1 Sept 2015 | AstraZeneca and Valeant to partner on brodalumab | RNS | |
| 28/08/15 | 17:00:17 | 28 Aug 2015 | Director/PDMR Shareholding | RNS | |
| 24/08/15 | 08:00:21 | 24 Aug 2015 | AstraZeneca appoints Dr Sean Bohen | RNS | |
| 03/08/15 | 16:00:59 | 3 Aug 2015 | Total Voting Rights | RNS | |
| 30/07/15 | 08:01:06 | 30 Jul 2015 | Half Yearly Report | RNS | |
| 29/07/15 | 10:00:05 | 29 Jul 2015 | Notice of Results | RNS | |
| 27/07/15 | 12:00:05 | 27 Jul 2015 | Confirmation of Change in ADS Ratio | RNS | |
| 27/07/15 | 08:00:14 | 27 Jul 2015 | AstraZeneca agreement with Genzyme on Caprelsa | RNS | |
| 17/07/15 | 12:00:02 | 17 Jul 2015 | Holding(s) in Company | RNS | |
| 17/07/15 | 08:05:37 | 17 Jul 2015 | AZ completes agreement with Tillotts for Entocort | RNS | |
| 14/07/15 | 08:00:14 | 14 Jul 2015 | IRESSA approved by US FDA | RNS | |
| 09/07/15 | 08:32:32 | 9 Jul 2015 | Agreement with Tillotts on Entocort | RNS | |
| 01/07/15 | 12:00:03 | 1 Jul 2015 | Total Voting Rights | RNS | |
| 26/06/15 | 13:00:02 | 26 Jun 2015 | Change in ADS ratio | RNS | |
| 25/06/15 | 12:30:04 | 25 Jun 2015 | Publication of Prospectus | RNS | |
| 16/06/15 | 15:00:05 | 16 Jun 2015 | Director/PDMR Shareholding | RNS | |
| 03/06/15 | 16:00:04 | 3 Jun 2015 | Holding(s) in Company | RNS | |
| 01/06/15 | 16:00:04 | 1 Jun 2015 | AstraZeneca PLC - Blocklisting Interim Review | RNS | |
| 01/06/15 | 16:00:04 | 1 Jun 2015 | Total Voting Rights | RNS | |
| 26/05/15 | 08:01:25 | 26 May 2015 | UPDATE ON BRODALUMAB DEVELOPMENT PROGRAMME | RNS | |
| 13/05/15 | 16:00:04 | 13 May 2015 | Holding(s) in Company | RNS | |
| 08/05/15 | 15:00:12 | 8 May 2015 | Director/PDMR Shareholding | RNS | |
| 08/05/15 | 12:00:04 | 8 May 2015 | Director/PDMR Shareholding - Replacement | RNS | |
| 08/05/15 | 11:00:07 | 8 May 2015 | Director/PDMR Shareholding | RNS | |
| 07/05/15 | 15:00:07 | 7 May 2015 | Director Declaration | RNS | |
| 01/05/15 | 17:00:03 | 1 May 2015 | Director/PDMR Shareholding | RNS | |
| 01/05/15 | 12:00:06 | 1 May 2015 | Total Voting Rights | RNS | |
| 29/04/15 | 18:30:02 | 29 Apr 2015 | Director/PDMR Shareholding | RNS | |
| 24/04/15 | 18:30:03 | 24 Apr 2015 | Result of AGM | RNS | |
| 24/04/15 | 08:02:04 | 24 Apr 2015 | 1st Quarter Results | RNS | |
| 24/04/15 | 08:01:20 | 24 Apr 2015 | Collaboration with Celgene on PD-L1 in haematology | RNS | |
| 24/04/15 | 08:00:40 | 24 Apr 2015 | AZ and Innate to collaborate in immuno-oncology | RNS | |
| 23/04/15 | 10:00:02 | 23 Apr 2015 | Notice of Results | RNS | |
| 17/04/15 | 08:00:18 | 17 Apr 2015 | Selumetinib granted Orphan Drug Designation by FDA | RNS | |
| 15/04/15 | 08:02:02 | 15 Apr 2015 | Tremelimumab granted Orphan Drug Designation | RNS | |
| 15/04/15 | 08:00:24 | 15 Apr 2015 | FDA REVIEWS SAVOR OUTCOMES STUDY RESULTS | RNS | |
| 01/04/15 | 12:00:08 | 1 Apr 2015 | Total Voting Rights | RNS | |
| 30/03/15 | 16:00:03 | 30 Mar 2015 | Director/PDMR Shareholding | RNS | |
| 19/03/15 | 11:00:03 | 19 Mar 2015 | Notice of AGM | RNS | |
| 19/03/15 | 07:00:24 | 19 Mar 2015 | COLLABORATION WITH DAIICHI SANKYO INC | RNS | |
| 18/03/15 | 07:04:45 | 18 Mar 2015 | POSITIVE PHASE III RESULTS FOR PT003 IN COPD | RNS | |
| 16/03/15 | 07:00:10 | 16 Mar 2015 | BRILINTA PEGASUS-TIMI 54 STUDY | RNS | |
| 10/03/15 | 18:24:05 | 10 Mar 2015 | Filing of Form 20-F with SEC | RNS | |
| 10/03/15 | 11:00:07 | 10 Mar 2015 | Annual Financial Report | RNS | |
| 06/03/15 | 07:00:22 | 6 Mar 2015 | ASTRAZENECA REFINES ITS FINANCIAL REPORTING | RNS |
| Date | TitleTitle | ||||
|---|---|---|---|---|---|
| 01/10/15 | 15:00:09 | 1 Oct 2015 | Director/PDMR Shareholding | RNS | |
| 28/09/15 | 15:30:13 | 28 Sept 2015 | Director/PDMR Shareholding | RNS | |
| 28/09/15 | 15:30:13 | 28 Sept 2015 | Director/PDMR Shareholding | RNS | |
| 04/09/15 | 08:00:09 | 4 Sept 2015 | US FDA APPROVES EXPANDED INDICATION FOR BRILINTA | RNS | |
| 01/09/15 | 12:30:04 | 1 Sept 2015 | Total Voting Rights | RNS | |
| 01/09/15 | 08:04:02 | 1 Sept 2015 | AstraZeneca and Valeant to partner on brodalumab | RNS | |
| 28/08/15 | 17:00:17 | 28 Aug 2015 | Director/PDMR Shareholding | RNS | |
| 24/08/15 | 08:00:21 | 24 Aug 2015 | AstraZeneca appoints Dr Sean Bohen | RNS | |
| 03/08/15 | 16:00:59 | 3 Aug 2015 | Total Voting Rights | RNS | |
| 30/07/15 | 08:01:06 | 30 Jul 2015 | Half Yearly Report | RNS | |
| 29/07/15 | 10:00:05 | 29 Jul 2015 | Notice of Results | RNS | |
| 27/07/15 | 12:00:05 | 27 Jul 2015 | Confirmation of Change in ADS Ratio | RNS | |
| 27/07/15 | 08:00:14 | 27 Jul 2015 | AstraZeneca agreement with Genzyme on Caprelsa | RNS | |
| 17/07/15 | 12:00:02 | 17 Jul 2015 | Holding(s) in Company | RNS | |
| 17/07/15 | 08:05:37 | 17 Jul 2015 | AZ completes agreement with Tillotts for Entocort | RNS | |
| 14/07/15 | 08:00:14 | 14 Jul 2015 | IRESSA approved by US FDA | RNS | |
| 09/07/15 | 08:32:32 | 9 Jul 2015 | Agreement with Tillotts on Entocort | RNS | |
| 01/07/15 | 12:00:03 | 1 Jul 2015 | Total Voting Rights | RNS | |
| 26/06/15 | 13:00:02 | 26 Jun 2015 | Change in ADS ratio | RNS | |
| 25/06/15 | 12:30:04 | 25 Jun 2015 | Publication of Prospectus | RNS | |
| 16/06/15 | 15:00:05 | 16 Jun 2015 | Director/PDMR Shareholding | RNS | |
| 03/06/15 | 16:00:04 | 3 Jun 2015 | Holding(s) in Company | RNS | |
| 01/06/15 | 16:00:04 | 1 Jun 2015 | AstraZeneca PLC - Blocklisting Interim Review | RNS | |
| 01/06/15 | 16:00:04 | 1 Jun 2015 | Total Voting Rights | RNS | |
| 26/05/15 | 08:01:25 | 26 May 2015 | UPDATE ON BRODALUMAB DEVELOPMENT PROGRAMME | RNS | |
| 13/05/15 | 16:00:04 | 13 May 2015 | Holding(s) in Company | RNS | |
| 08/05/15 | 15:00:12 | 8 May 2015 | Director/PDMR Shareholding | RNS | |
| 08/05/15 | 12:00:04 | 8 May 2015 | Director/PDMR Shareholding - Replacement | RNS | |
| 08/05/15 | 11:00:07 | 8 May 2015 | Director/PDMR Shareholding | RNS | |
| 07/05/15 | 15:00:07 | 7 May 2015 | Director Declaration | RNS | |
| 01/05/15 | 17:00:03 | 1 May 2015 | Director/PDMR Shareholding | RNS | |
| 01/05/15 | 12:00:06 | 1 May 2015 | Total Voting Rights | RNS | |
| 29/04/15 | 18:30:02 | 29 Apr 2015 | Director/PDMR Shareholding | RNS | |
| 24/04/15 | 18:30:03 | 24 Apr 2015 | Result of AGM | RNS | |
| 24/04/15 | 08:02:04 | 24 Apr 2015 | 1st Quarter Results | RNS | |
| 24/04/15 | 08:01:20 | 24 Apr 2015 | Collaboration with Celgene on PD-L1 in haematology | RNS | |
| 24/04/15 | 08:00:40 | 24 Apr 2015 | AZ and Innate to collaborate in immuno-oncology | RNS | |
| 23/04/15 | 10:00:02 | 23 Apr 2015 | Notice of Results | RNS | |
| 17/04/15 | 08:00:18 | 17 Apr 2015 | Selumetinib granted Orphan Drug Designation by FDA | RNS | |
| 15/04/15 | 08:02:02 | 15 Apr 2015 | Tremelimumab granted Orphan Drug Designation | RNS | |
| 15/04/15 | 08:00:24 | 15 Apr 2015 | FDA REVIEWS SAVOR OUTCOMES STUDY RESULTS | RNS | |
| 01/04/15 | 12:00:08 | 1 Apr 2015 | Total Voting Rights | RNS | |
| 30/03/15 | 16:00:03 | 30 Mar 2015 | Director/PDMR Shareholding | RNS | |
| 19/03/15 | 11:00:03 | 19 Mar 2015 | Notice of AGM | RNS | |
| 19/03/15 | 07:00:24 | 19 Mar 2015 | COLLABORATION WITH DAIICHI SANKYO INC | RNS | |
| 18/03/15 | 07:04:45 | 18 Mar 2015 | POSITIVE PHASE III RESULTS FOR PT003 IN COPD | RNS | |
| 16/03/15 | 07:00:10 | 16 Mar 2015 | BRILINTA PEGASUS-TIMI 54 STUDY | RNS | |
| 10/03/15 | 18:24:05 | 10 Mar 2015 | Filing of Form 20-F with SEC | RNS | |
| 10/03/15 | 11:00:07 | 10 Mar 2015 | Annual Financial Report | RNS | |
| 06/03/15 | 07:00:22 | 6 Mar 2015 | ASTRAZENECA REFINES ITS FINANCIAL REPORTING | RNS |